Rafael Díaz

Also affiliated with Instituto Cardiovascular de Rosario

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction”.

Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction

JACC Heart Failure(2020)10.1016/j.jchf.2019.12.001

N/A

4.9DataRank · unranked

142 citations

Rafael Díaz, G. Michael Felker, John J.V. McMurray, Marco Metra, Scott D. Solomon +7 more

Impact of Complete Revascularization in the ISCHEMIA Trial

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.06.015

N/A

1.6DataRank · unranked

45 citations

Ziad A. Ali, Sean M. O’Brien, Grace L. Rhodes, Philippe Généreux, Sripal Bangalore +89 more

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2009)10.1056/nejmoa0905561

N/A

1.4DataRank · unranked

11147 citations

Michael D. Ezekowitz, Salim Yusuf, John Eikelboom, Jonas Oldgren, Amit Parekh +20 more

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2011)10.1056/nejmoa1107039

N/A

1.4DataRank · unranked

8849 citations

John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna +37 more

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

Journal of the American Heart Association(2023)10.1161/jaha.122.029216

N/A

1.1DataRank · unranked

40 citations

Philippe Gabríel Steg, Yann Poulouin, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +10 more

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab

European Journal of Preventive Cardiology(2022)10.1093/eurjpc/zwac107

N/A

0.846DataRank · unranked

15 citations

Jennifer McGinniss, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +12 more

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae025

N/A

0.483DataRank · unranked

24 citations

Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +82 more

Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial

The American Journal of Medicine(2022)10.1016/j.amjmed.2022.02.016

N/A

0.401DataRank · unranked

5 citations

Patrícia O. Guimarães, Gregory G. Schwartz, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj +13 more

Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2023.11.021

N/A

0.358DataRank · unranked

6 citations

Scott Solomon, Marco Metra, John J.V. McMurray, Rafael Díaz, Brian Claggett +15 more

Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2023)10.1016/j.jchf.2022.11.021

N/A

0.208DataRank · unranked

3 citations

Joyce Njoroge, Kirkwood F. Adams, Inder S. Anand, James C. Fang, Félix José Alvarez Ramires +17 more

Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT

Journal of Cardiac Failure(2022)10.1016/j.cardfail.2022.05.004

N/A

0DataRank · unranked

7 citations

Brian Claggett, Eldrin F. Lewis, Eileen O’Meara, Nadine Clausell, Rafael Díaz +7 more

The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2023.08.020

N/A

0DataRank · unranked

7 citations

John J.V. McMurray, Rafael Díaz, G. Michael Felker, Marco Metra, Scott D. Solomon +19 more

Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

The Lancet Planetary Health(2020)10.1016/s2542-5196(20)30103-0

N/A

0DataRank · unranked

202 citations

Andrew Larkin, Sumathy Rangarajan, Khalid F. AlHabib, Álvaro Avezum, Kevser Burcu Tümerdem Çalık +26 more